City Insurance PLC. announcements
354 Dhaka Stock Exchange announcements for City Insurance PLC. (CITYGENINS) since 2008: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2023 (21).
- (Q3 Un-audited): EPS was Tk. 0.77 for July-September 2023 as against Tk. 0.57 for July-September 2022; EPS was Tk. 2.12
(Q3 Un-audited): EPS was Tk. 0.77 for July-September 2023 as against Tk. 0.57 for July-September 2022; EPS was Tk. 2.12 for January-September 2023 as against Tk. 1.61 for January-September 2022. NOCFPS was Tk. 1.84 for January-September 2023 as against Tk. 4.28 for January-September 2022. NAV per share was Tk. 20.42 as on September 30, 2023 and Tk. 19.15 as on September 30, 2022. The Company has also informed that EPS has been increased (cont.)
- Q3 Financials
(Continuation news of CITYGENINS): for the period from 01 January 2023 to 30 September 2023 in comparison to the same period of the previous year 2022 because of management expenses have been decreased and investment and others income have been increased. NOCFPS has been decreased because of the company's re-insurance and others payment have been increased. NAV per share has been increased because of the company's investments in Bangladesh Govt. Treasury Bond and FDR have been increased. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 23, 2023 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2023.
- (Q2 Un-audited): EPS was Tk. 0.81 for April-June 2023 as against Tk. 0.65 for April-June 2022; EPS was Tk. 1.35 for Janu
(Q2 Un-audited): EPS was Tk. 0.81 for April-June 2023 as against Tk. 0.65 for April-June 2022; EPS was Tk. 1.35 for January-June 2023 as against Tk. 1.04 for January-June 2022. NOCFPS was Tk. 1.25 for January-June 2023 as against Tk. 3.34 for January-June 2022. NAV per share was Tk. 19.70 as on June 30, 2023 and 18.57 as on December 31, 2022. The reasons for deviation in EPS, NOCFPS and NAVPS: (cont.)
- Q2 Financials
(Continuation news of CITYGENINS): EPS has been increased due to decrease in claim and management expenses, and increase in investments and other income. NOCFPS has been decreased due to increase in company's re-insurance and other payment. NAVPS has been increased due to increase in company's investments in shares and FDR. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 16, 2023 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2023.
- Credit Rating Information and Services Limited (CRISL) has assigned the Rating of the Company as \"CPA AA+\" in the long
Credit Rating Information and Services Limited (CRISL) has assigned the Rating of the Company as \"CPA AA+\" in the long term along with Stable outlook based on audited financials of the Company up to December 31, 2022; unaudited financials up to March 31, 2023 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Retirement & appointment of New Company Secretary (Acting)
The Company has informed that Mr. Md. Hasan Khan, Additional Managing Director and Company Secretary has retired from the service of the company with effect from May 12, 2023 and Mr. Mohammed Ashaduzzaman Sarkar has been appointed as new Company Secretary (Acting) with effect from May 14, 2023.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended December 31, 2022 to the respective shareholders.
- (Q1 Un-audited): EPS was Tk. 0.54 for January-March 2023 as against Tk. 0.39 for January-March 2022. NOCFPS was Tk. 0.48
(Q1 Un-audited): EPS was Tk. 0.54 for January-March 2023 as against Tk. 0.39 for January-March 2022. NOCFPS was Tk. 0.48 for January-March 2023 as against Tk. 1.33 for January-March 2022. NAV per share was Tk. 19.18 as on March 31, 2023 and Tk. 18.57 as on December 31, 2022. Reasons for Significant deviation in EPS, NOCFPS and NAV: EPS has been increased because of investment and others income (cont.)
- Q1 Financials
(Continuation news of CITYGENINS): have been increased steadily and management expenses have been decreased. NOCFPS has been decreased as the company's premium collection has been decreased. NAV per share has been increased as the company's investments in share and FDR have been increased. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 18, 2023 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2023.
- Update of Information (Additional)
The Company has further requested the concerned Brokerage Houses/DPs to provide the statement both hard and soft copy to [email protected] with details of their margin loan holders entitled to Final Dividend 2022 on or before March 20, 2023. The statement should include Shareholder's name, BOID Number, e-mail, client-wise shareholding position, contact person etc. The record date was March 07, 2023.
- Update of Information
The company has requested the Shareholders to update their Bank Account number, E-mail ID, Mobile number through their respective Depository Participants (DP).
- Resumption after record date
Trading of the shares of the company will resume on 09.03.2023.
- Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e., 07.03.2023.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 05.03.2023 to 06.03.2023 and trading of the shares will remain suspended on record date i.e., 07.03.2023.
- The Board of Directors has recommended 10.50\% Cash Dividend for the year ended December 31, 2022. Date of AGM: 30.03.20
The Board of Directors has recommended 10.50\% Cash Dividend for the year ended December 31, 2022. Date of AGM: 30.03.2023, Time: 2:30 PM, Venue: Digital Platform. Record date: 07.03.2023. The Company has also reported EPS of Tk. 2.25, NAV per share of Tk. 18.57 and NOCFPS of Tk. 5.59 for the year ended December 31, 2022 as against Tk. 1.68, Tk. 17.53 and Tk. 2.75 respectively for the same period of the previous year. Reasons for deviation in EPS, NAVPS and NOCFPS: (cont.)
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (14.02.2023) following its corporate declaration.
- Dividend Declaration
(Continuation news of CITYGENINS): EPS has been increased due to increase of company's premium income significantly. NOCFPS has been increased due to increase of company's premium income sharply. NAV per share has been increased due to increase of company's investments in share, Govt. Treasury Bond and FDR. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on February 13, 2023 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2022.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.